Femring and medical device complication Patient Reports February 10, 2012

Femring Side Effects Report #5303017-8
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2007. Female patient, 56 years of age, weighting 158.1 lb, was diagnosed with vulvovaginal dryness and was treated with Femring. After drug was administered, patient experienced the following side effects: abdominal pain , dyspnoea, hiatus hernia, medical device complication, ovarian cyst , procedural pain, thyroid disorder. Femring dosage: 0.05 MG, QD; VAGINAL. During the same period patient was treated with SYNTHROID, DIOVAN HCT, PREVACID, NEXIUM, VITAMIN, FISH OIL, POTASSIUM, CALCIUM. Patient was hospitalized. Patient recovered.

Femring Side Effects Report #5504042-4
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 18, 2007. Female patient, 34 years of age, weighting 115.1 lb, was diagnosed with vulvovaginal discomfort, vulvovaginal dryness and was treated with Femring. After drug was administered, patient experienced the following side effects: chest pain , heart rate irregular, hormone level abnormal, hot flush, loss of consciousness, medical device complication, night sweats. Femring dosage: 0.1 MG, QD, VAGINAL. During the same period patient was treated with NADOLOL, LIPITOR, CARDIZEM, PREMARIN. Patient was hospitalized. Patient recovered.

Femring Side Effects Report #4643375-0
Femring side effect was reported by a Physician from on Apr 13, 2005. Female patient, 61 years of age, weighting 155.9 lb, was diagnosed with menopausal symptoms and was treated with Femring. After drug was administered, patient experienced the following side effects: antinuclear antibody positive, dyspareunia, excessive granulation tissue, medical device complication, vaginal disorder, vaginal examination abnormal. Femring dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with LIPITOR. Patient recovered.

Femring Side Effects Report #4920806-X
Femring side effect was reported by a Physician from UNITED STATES on May 13, 2004. Female patient, 61 years of age, weighting 155.9 lb, was diagnosed with menopausal symptoms and was treated with Femring. After drug was administered, patient experienced the following side effects: dyspareunia, hyperkeratosis, medical device complication, post procedural complication, rectocele, vaginal disorder, vaginal infection. Femring dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with LIPITOR, PREMARIN, CALCIUM, ACTONEL. Patient recovered.


Femring Side Effects Report #4779567-X
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 04, 2004. Female patient, 52 years of age, weighting 173.1 lb, was diagnosed with menopausal symptoms and was treated with Femring. After drug was administered, patient experienced the following side effects: diarrhoea, fall , foot fracture, hot flush, medical device complication, migraine , motion sickness , nausea , pulmonary embolism . Femring dosage: unknown. During the same period patient was treated with VIOXX, PREDNISONE, REMICADE, PREVACID, ZANTAC, IMITREX, BEXTRA. Patient was hospitalized. Patient recovered.

Femring Side Effects Report #4860544-5
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 07, 2005. Female patient, 54 years of age, weighting 177.9 lb, was diagnosed with artificial menopause and was treated with Femring. After drug was administered, patient experienced the following side effects: medical device complication, vaginal haemorrhage. Femring dosage: 0.05 MG, QD, VAGINAL. Patient recovered.

Femring Side Effects Report #5379555-9
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Female patient, 56 years of age, weighting 194.9 lb, was treated with Femring. After drug was administered, patient experienced the following side effects: histoplasmosis, medical device complication, pneumonia , procedural pain, skeletal injury. Femring dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with SYNTHROID, ACIPHEX, VALIUM, CLONIDINE, BUPROPION, LIPITOR, BONIVA, MIRALAX. Patient was hospitalized. Patient recovered.